JDD analysis highlights racial gaps in JAK inhibitor dermatology trials Have you caught this new JDD, analysis on JAK inhibitor trials? Dermatologists and clinical investigators will likely find this review relevant…
Read More
In skin of color, halo phenomena can mask benign lesions; biopsy and dermoscopic‑pathologic correlation remain essential It’s time to dive into one of our January JDD case reports ! A…
Read More
From the Vault: Vitiligo trials lag on diversity - US studies underrepresent non‑White and Hispanic patients We are pulling this article from the JDD vault. It’s a July 2024 article…
Read More
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Read More
